CLOs on the Move

TriCore

www.tricore.org

 
TriCore Reference Laboratories is a community-based, independent, clinical reference laboratory that provides full-service, state-of-the-art laboratory tests to health care professionals and their patients. Based in Albuquerque, N.M., with clients in New Mexico and across the US. TriCore offers more than 1,500 laboratory tests ranging from routine (such as cholesterol screens) to highly specialized (such as genetic testing). TriCore participates in scientific research through collaboration with the University of New Mexico and numerous national and international biotech firms.
  • Number of Employees: 1K-5K
  • Annual Revenue: $100-250 Million
  • www.tricore.org
  • 1001 Woodward Place NorthEast
    Albuquerque, NM USA 87102
  • Phone: 505.938.8888

Executives

Name Title Contact Details
Michelle Neel
Senior Director, Compliance Profile

Similar Companies

Imaging Systems Inc

Imaging Systems Inc is a Peachtree City, GA-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

Patterson Medical

Patterson Medical is a Columbia, SC-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

Ferring Pharmaceuticals

Ferring Pharmaceuticals is a private multinational biopharmaceutical company specialising in areas such as reproductive health, maternal health, gastroenterology and urology. Ferring has been developing treatments for mothers and babies for over 50 years.

Humacyte

Humacyte, Inc. (Nasdaq: HUMA) is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. The Company develops and manufactures acellular tissues to treat a wide range of diseases, injuries and chronic conditions. Humacyte`s initial opportunity, a portfolio of human acellular vessels (HAVs), is currently in late-stage clinical trials targeting multiple vascular applications, including vascular trauma repair, arteriovenous access for hemodialysis, and peripheral arterial disease. Preclinical development is also underway in coronary artery bypass grafts, pediatric heart surgery, treatment of type 1 diabetes, and multiple novel cell and tissue applications. Humacyte`s 6mm HAVs for AV access for performing hemodialysis was the first product candidate to receive the FDA`s Regenerative Medicine Advanced Therapy (RMAT) expedited review designation, and the HAV technology received priority designation for the treatment of vascular trauma by the U.S. Secretary of Defense.

Blue Elm

Blue Elm is a Westwood, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.